S. Creutzburg

A Novel Type of Bifunctional Inhibitor Directed against Proteolytic Activity and Receptor/Ligand Interaction

M. Schmitt, E. Auerswald, S. G. Parrado, 2000, The Journal of Biological Chemistry.

Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptides.

N. Schmiedeberg, M. Schmitt, H. Kessler, 2000, Thrombosis research.

Expression of the human urokinase‐type plasminogen activator receptor in E. coli and Chinese hamster ovary cells: Purification of the recombinant proteins and generation of polyclonal antibodies in chicken

U. Weidle, M. Schmitt, V. Magdolen, 1995, Electrophoresis.

Interdependence of kallikrein-related peptidases in proteolytic networks

M. Schmitt, V. Magdolen, S. Creutzburg, 2010, Biological chemistry.

Interplay of human tissue kallikrein 4 (hK4) with the plasminogen activation system: hK4 regulates the structure and functions of the urokinase-type plasminogen activator receptor (uPAR)

W. Bode, M. Schmitt, V. Magdolen, 2006, Biological chemistry.

Non-muscle α-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAI-1)

M. Schmitt, V. Magdolen, U. Magdolen, 2004 .

Mutational analysis of the genes encoding urokinase‐type plasminogen activator (uPA) and its inhibitor PAI‐1 in advanced ovarian cancer

M. Schmitt, V. Magdolen, H. Graeff, 1997, Electrophoresis.

Quantitative assessment of interaction of urokinase-type plasminogen activator and its receptor (CD87) by use of a solid-phase uPA-ligand binding assay

U. Weidle, M. Schmitt, H. Kessler, 1997 .